Manyu Prakash

Suggest Changes
Learn More
Results At baseline, more patients were HCV antibody positive by serology in the DRV/r arm (17%) than in the control arm (9%). In the primary efficacy analysis at Week 48, 86.2% of patients in the(More)
  • 1